Cargando…
SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis
There is ongoing debate as to whether cardiac complications of coronavirus disease-2019 (COVID-19) result from myocardial viral infection or are secondary to systemic inflammation and/or thrombosis. We provide evidence that cardiomyocytes are infected in patients with COVID-19 myocarditis and are su...
Autores principales: | Bailey, Adam L., Dmytrenko, Oleksandr, Greenberg, Lina, Bredemeyer, Andrea L., Ma, Pan, Liu, Jing, Penna, Vinay, Winkler, Emma S., Sviben, Sanja, Brooks, Erin, Nair, Ajith P., Heck, Kent A., Rali, Aniket S., Simpson, Leo, Saririan, Mehrdad, Hobohm, Dan, Stump, W. Tom, Fitzpatrick, James A., Xie, Xuping, Zhang, Xianwen, Shi, Pei-Yong, Hinson, J. Travis, Gi, Weng-Tein, Schmidt, Constanze, Leuschner, Florian, Lin, Chieh-Yu, Diamond, Michael S., Greenberg, Michael J., Lavine, Kory J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909907/ https://www.ncbi.nlm.nih.gov/pubmed/33681537 http://dx.doi.org/10.1016/j.jacbts.2021.01.002 |
Ejemplares similares
-
CCL17 Protects Against Viral Myocarditis by Suppressing the Recruitment of Regulatory T Cells
por: Feng, Guoshuai, et al.
Publicado: (2023) -
Cardiovascular Tropism and Sequelae of SARS-CoV-2 Infection
por: Dmytrenko, Oleksandr, et al.
Publicado: (2022) -
Myocarditis after Covid-19 mRNA Vaccination
por: Verma, Amanda K., et al.
Publicado: (2021) -
Expansion of Disease Specific Cardiac Macrophages in Immune Checkpoint Inhibitor Myocarditis
por: Ma, Pan, et al.
Publicado: (2023) -
Clinicopathological classification of immune checkpoint inhibitor-associated myocarditis: possible refinement by measuring macrophage abundance
por: Jimenez, Jesus, et al.
Publicado: (2023)